Drug Maker Acknowledges Misleading Claims
The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.
Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on November 30, 2015, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/